Abbott integrates CGM into Tandem's automated insulin pump

$ 7.00

4.7
(493)
In stock
Description

Abbott (NYSEABT) and Tandem Diabetes Care (Nasdaq:TNDM) announced the integration of FreeStyle Libre 2 CGM into the t:slim X2 insulin pump.

U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems - Mar 6, 2023

Insulin Delivery Device Technology — Today and Into the Future - Today's Dietitian Magazine

Tandem Diabetes Care Launches Insulin Pump With Dexcom G5 Mobile CGM Integration

Manuel Hernández على LinkedIn: Environmental Protection Specialist

Abbott & Tandem Integrate to Bring Automated Insulin Delivery to US

Barriers to uptake of insulin technologies

Drug Delivery Business News on LinkedIn: Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI…

Erica Scott - CSAM on LinkedIn: Vertex cuts ties to CRISPR Therapeutics' type 1 diabetes stem cell therapy

Abbott and Tandem integrate insulin devices - HealthTekPak

Tandem — Healthy Living Blog — Healthy Living Medical Supply

Diabetes Care Technology Coming In 2023

Ahmed Sasi on LinkedIn: Exploring the Therapeutic Potential of Once Weekly Basal Insulin Therapy

Continuous Glucose Monitoring (CGM): What It Is and Who Can Benefit